Diabetic Retinopathy May Increase Risk for COVID-19 Intubation
For patients with diabetes hospitalized with COVID-19, the risk for intubation is increased more than fivefold for those with diabetic retinopathy.
Type 2 Diabetes
Hemoglobin A1c During Early Pregnancy Predicts Beta-Cell Dysfunction in Women With Gestational Diabetes Risk
Researchers examined the association between HbA1c during early pregnancy and beta-cell function in women with gestational diabetes risk.
CVD Risk Higher in T2DM Even With Optimal Risk Factor Management
Patients with type 2 diabetes with optimally managed risk factor control have increased cardiovascular disease.
Sotagliflozin Reduces Risk for Adverse CV Events in Diabetic Kidney Disease
Sotagliflozin might help patients with diabetes and chronic kidney disease who are hospitalized with heart failure avoid a readmission, study results suggest.
Group-Based Lifestyle Intervention Reduces T2DM Progression
A low-cost, group-delivered lifestyle intervention is associated with a significantly lower risk for progression to type 2 diabetes among high-risk individuals.
SGLT2 Inhibitors Reduce CV, Kidney Event Risk Regardless of Metformin Use
Investigators evaluated whether the effects of SGLT2 inhibitors on cardiovascular, kidney and mortality outcomes are the same with and without concomitant metformin use.
Lifestyle Intervention and Risk for MI, Heart Failure in T2D
An intensive lifestyle intervention was found to be associated with a significant loss of fat mass and lean mass in adults with type 2 diabetes.
CDC: 26.4% of Adults With Diabetes Meet Goals to Prevent Complications
About one in four U.S. adults (26.4 percent) with diabetes meet the combined goals for preventing or delaying complications of diabetes.
Increased Risk for Type 2 Diabetes Among Adolescents With Fatty Liver
This study evaluated risk for type 2 diabetes among more than 1 million adolescents in Israel with and without nonalcoholic fatty liver disease.
Can NRTIs Be Repurposed to Reduce Risk for T2D Development?
Evidence suggests that a class of drugs used to treat HIV and hepatitis B can reduce a patient’s risk for developing type 2 diabetes.
-
Loading...
-
Loading...
Next post in Diabetes
